How Therapeutic Formulations Affect Medical Device Patents

Law360 (July 6, 2020, 5:30 PM EDT) -- Medical devices that (1) are configured to deliver a therapeutic formulation and (2) are packaged with a preloaded dose of the to-be-delivered formulation are becoming more common.

For patients, these medical devices can conveniently provide a predetermined dose — for example, a unit dose — of the therapeutic formulation. This can help ensure patients receive the correct dose or amount of the formulation, and that the dose or amount is correctly administered, thereby reducing the occurrence of dosage and administration associated adverse effects.

Preloaded devices can also increase patient compliance with a therapeutic regimen, and depending on the device, provide convenience...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!